Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Return on Assets (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Return on Assets for 12 consecutive years, with 0.07% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets rose 20.0% to 0.07% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.07%, a 20.0% increase, with the full-year FY2020 number at 0.04%, up 53.0% from a year prior.
  • Return on Assets was 0.07% for Q3 2025 at Theravance Biopharma, up from 0.03% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 1.81% in Q2 2023 to a low of 0.69% in Q1 2021.
  • A 5-year average of 0.22% and a median of 0.14% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: surged 208bps in 2022, then crashed -195bps in 2024.
  • Theravance Biopharma's Return on Assets stood at 0.48% in 2021, then soared by 395bps to 1.41% in 2022, then tumbled by -107bps to 0.1% in 2023, then crashed by -56bps to 0.16% in 2024, then soared by 145bps to 0.07% in 2025.
  • Per Business Quant, the three most recent readings for TBPH's Return on Assets are 0.07% (Q3 2025), 0.03% (Q2 2025), and 0.16% (Q1 2025).